Lung Transplant Fellowship Supported by the Hertz Family

The University of Minnesota Pulmonary, Allergy, Critical Care and Sleep Medicine Division offers a one-year Lung Transplant Training Program made possible through the generosity of the Hertz Family.

Dr. Marshall Hertz was the medical director for the UMN Lung Transplant Program, one of the first programs in the country, from 1986-2021, during which the program performed more than 1,200 lung transplants, making it one of the most experienced and well-recognized centers in the United States and worldwide. As an early innovator in the field, the UMN lung transplant program was a model for many other programs and known for high quality and performance, drawing patients from around the country. We are thankful for the years of leadership and support provided by the Hertz family.

This one-year fellowship focuses entirely on lung transplant, with emphasis on both clinical training and research. It is a non-ACGME accredited training program.

Lung Transplant Fellows receive training at the University of Minnesota Medical Center, a tertiary referral hospital. The division has 48 faculty members who have a broad range of clinical and research interests. The Division has expertise in all areas of advanced lung diseases such as ILD (pulmonary fibrosis care center), interventional pulmonology, cystic fibrosis, and pulmonary hypertension. Basic science and clinical research projects in the areas of interstitial lung diseases, acute lung injury, lung transplantation, alternative modes of mechanical ventilation, bacterial pneumonia, and chronic obstructive lung disease are currently ongoing among the four hospital sites associated with the Division.

All Lung Transplant Fellows will engage in a structured program of clinical training when not serving on the Pulmonary Transplant service. 

The primary goals for fellows completing the program are:

  1. Be qualified for certification as a Lung Transplant Pulmonologist, based on the requirements of the United Network for Organ Sharing.
  2. Be qualified to engage in retrospective and prospective clinical research studies related to lung transplantation.
  3. Be qualified to engage in scholarly activity related to lung transplant medicine.

Research activities include, but are not limited to the following:

  1. Design and completion of investigator-initiated clinical research projects involving retrospective patient chart reviews.
  2. Development of abstracts and/or manuscripts related to individual projects.
  3. Presenting and networking at international/national conferences.
Eligibility

To be eligible for consideration, applicants must have:

  • Candidates must be board certified in pulmonary and critical care, or be in the third year of an ACGME-accredited fellowship and board eligible for pulmonary and critical care
  • US citizenship or permanent resident status is required; the program is unable to consider J1 or H-1B visa holders at this time.
Application

The program has been filled for the upcoming academic year. Applications for July 2027 may be submitted from July 15 through November 1, 2026. 

To apply, please submit the following to [email protected]:

  • Curriculum vitae
  • One-page personal statement
  • 2 - 3 letters of recommendation (LOR), including one from the Pulmonary/Critical Care Medicine fellowship program director

Program Director

Image of Dr. Sarah Kiel

Sarah Kiel, MD
Read full bio

For questions or to apply, please email [email protected].